EMEA (Europe, Middle East and Africa) MAb Biosimilars Market Report 2017

August 2017 | 111 pages | ID: E84E7C57896EN
QYResearch

Abstracts

In this report, the EMEA MAb Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of MAb Biosimilars for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA MAb Biosimilars market competition by top manufacturers/players, with MAb Biosimilars sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Biocon
• Celltrion
• Dr. Reddy's Laboratories
• Hospira
• 3SBio
• Accord Healthcare
• AET Biotech
• Allergan
• Alvartis Pharma
• Amega Biotech
• Amgen
• Apotex
• BioXpress Therapeutics
• Natco Pharma
• Sanifo
• Synthon

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Synthetic chemicls
• Biopharmaceuticals
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of MAb Biosimilars for each application, including

• Chronic and autoimmune diseases
• Oncology

Contents

EMEA (Europe, Middle East and Africa) MAb Biosimilars Market Report 2017

1 MAB BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of MAb Biosimilars
1.2 Classification of MAb Biosimilars
  1.2.1 EMEA MAb Biosimilars Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA MAb Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Synthetic chemicls
  1.2.4 Biopharmaceuticals
  1.2.5 Others
1.3 EMEA MAb Biosimilars Market by Application/End Users
  1.3.1 EMEA MAb Biosimilars Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Chronic and autoimmune diseases
  1.3.3 Oncology
1.4 EMEA MAb Biosimilars Market by Region
  1.4.1 EMEA MAb Biosimilars Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of MAb Biosimilars (2012-2022)
  1.5.1 EMEA MAb Biosimilars Sales and Growth Rate (2012-2022)
  1.5.2 EMEA MAb Biosimilars Revenue and Growth Rate (2012-2022)

2 EMEA MAB BIOSIMILARS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA MAb Biosimilars Market Competition by Players/Manufacturers
  2.1.1 EMEA MAb Biosimilars Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA MAb Biosimilars Revenue and Share by Players (2012-2017)
  2.1.3 EMEA MAb Biosimilars Sale Price by Players (2012-2017)
2.2 EMEA MAb Biosimilars (Volume and Value) by Type/Product Category
  2.2.1 EMEA MAb Biosimilars Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA MAb Biosimilars Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA MAb Biosimilars Sale Price by Type (2012-2017)
2.3 EMEA MAb Biosimilars (Volume) by Application
2.4 EMEA MAb Biosimilars (Volume and Value) by Region
  2.4.1 EMEA MAb Biosimilars Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA MAb Biosimilars Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA MAb Biosimilars Sales Price by Region (2012-2017)

3 EUROPE MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe MAb Biosimilars Sales and Value (2012-2017)
  3.1.1 Europe MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe MAb Biosimilars Revenue and Growth Rate (2012-2017)
3.2 Europe MAb Biosimilars Sales and Market Share by Type
3.3 Europe MAb Biosimilars Sales and Market Share by Application
3.4 Europe MAb Biosimilars Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe MAb Biosimilars Sales Volume by Countries (2012-2017)
  3.4.2 Europe MAb Biosimilars Revenue by Countries (2012-2017)
  3.4.3 Germany MAb Biosimilars Sales and Growth Rate (2012-2017)
  3.4.4 France MAb Biosimilars Sales and Growth Rate (2012-2017)
  3.4.5 UK MAb Biosimilars Sales and Growth Rate (2012-2017)
  3.4.6 Russia MAb Biosimilars Sales and Growth Rate (2012-2017)
  3.4.7 Italy MAb Biosimilars Sales and Growth Rate (2012-2017)
  3.4.8 Benelux MAb Biosimilars Sales and Growth Rate (2012-2017)

4 MIDDLE EAST MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East MAb Biosimilars Sales and Value (2012-2017)
  4.1.1 Middle East MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East MAb Biosimilars Revenue and Growth Rate (2012-2017)
4.2 Middle East MAb Biosimilars Sales and Market Share by Type
4.3 Middle East MAb Biosimilars Sales and Market Share by Application
4.4 Middle East MAb Biosimilars Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East MAb Biosimilars Sales Volume by Countries (2012-2017)
  4.4.2 Middle East MAb Biosimilars Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia MAb Biosimilars Sales and Growth Rate (2012-2017)
  4.4.4 Israel MAb Biosimilars Sales and Growth Rate (2012-2017)
  4.4.5 UAE MAb Biosimilars Sales and Growth Rate (2012-2017)
  4.4.6 Iran MAb Biosimilars Sales and Growth Rate (2012-2017)

5 AFRICA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa MAb Biosimilars Sales and Value (2012-2017)
  5.1.1 Africa MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa MAb Biosimilars Revenue and Growth Rate (2012-2017)
5.2 Africa MAb Biosimilars Sales and Market Share by Type
5.3 Africa MAb Biosimilars Sales and Market Share by Application
5.4 Africa MAb Biosimilars Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa MAb Biosimilars Sales Volume by Countries (2012-2017)
  5.4.2 Africa MAb Biosimilars Revenue by Countries (2012-2017)
  5.4.3 South Africa MAb Biosimilars Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria MAb Biosimilars Sales and Growth Rate (2012-2017)
  5.4.5 Egypt MAb Biosimilars Sales and Growth Rate (2012-2017)
  5.4.6 Algeria MAb Biosimilars Sales and Growth Rate (2012-2017)

6 EMEA MAB BIOSIMILARS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Biocon
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 MAb Biosimilars Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Biocon MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Celltrion
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 MAb Biosimilars Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Celltrion MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Dr. Reddy's Laboratories
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 MAb Biosimilars Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dr. Reddy's Laboratories MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hospira
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 MAb Biosimilars Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hospira MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 3SBio
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 MAb Biosimilars Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 3SBio MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Accord Healthcare
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 MAb Biosimilars Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Accord Healthcare MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 AET Biotech
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 MAb Biosimilars Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AET Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Allergan
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 MAb Biosimilars Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Allergan MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Alvartis Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 MAb Biosimilars Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Alvartis Pharma MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Amega Biotech
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 MAb Biosimilars Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Amega Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Amgen
6.12 Apotex
6.13 BioXpress Therapeutics
6.14 Natco Pharma
6.15 Sanifo
6.16 Synthon

7 MAB BIOSIMILARS MANUFACTURING COST ANALYSIS

7.1 MAb Biosimilars Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of MAb Biosimilars

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 MAb Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of MAb Biosimilars Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA MAB BIOSIMILARS MARKET FORECAST (2017-2022)

11.1 EMEA MAb Biosimilars Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA MAb Biosimilars Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA MAb Biosimilars Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA MAb Biosimilars Price and Trend Forecast (2017-2022)
11.2 EMEA MAb Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe MAb Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt MAb Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa MAb Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA MAb Biosimilars Sales Forecast by Type (2017-2022)
11.7 EMEA MAb Biosimilars Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of MAb Biosimilars
Figure EMEA MAb Biosimilars Sales Volume (K Units) by Type (2012-2022)
Figure EMEA MAb Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic chemicls Product Picture
Figure Biopharmaceuticals Product Picture
Figure Others Product Picture
Figure EMEA MAb Biosimilars Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of MAb Biosimilars by Application in 2016
Figure Chronic and autoimmune diseases Examples
Figure Oncology Examples
Figure EMEA MAb Biosimilars Market Size (Million USD) by Region (2012-2022)
Figure Europe MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe MAb Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Middle East MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East MAb Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Africa MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa MAb Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure EMEA MAb Biosimilars Sales Volume and Growth Rate (2012-2022)
Figure EMEA MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA MAb Biosimilars Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA MAb Biosimilars Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA MAb Biosimilars Sales Share by Players (2012-2017)
Figure 2016 MAb Biosimilars Sales Share by Players
Figure 2017 MAb Biosimilars Sales Share by Players
Figure EMEA MAb Biosimilars Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA MAb Biosimilars Revenue (Million USD) by Players (2012-2017)
Table EMEA MAb Biosimilars Revenue Share by Players (2012-2017)
Table 2016 EMEA MAb Biosimilars Revenue Share by Players
Table 2017 EMEA MAb Biosimilars Revenue Share by Players
Table EMEA MAb Biosimilars Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA MAb Biosimilars Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA MAb Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Type (2012-2017)
Figure EMEA MAb Biosimilars Sales Market Share by Type (2012-2017)
Table EMEA MAb Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA MAb Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Type in 2016
Table EMEA MAb Biosimilars Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA MAb Biosimilars Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA MAb Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Application (2012-2017)
Figure EMEA MAb Biosimilars Sales Market Share by Application in 2016
Table EMEA MAb Biosimilars Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA MAb Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Region (2012-2017)
Figure EMEA MAb Biosimilars Sales Market Share in 2016
Table EMEA MAb Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA MAb Biosimilars Revenue Share by Region (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Region (2012-2017)
Figure EMEA MAb Biosimilars Revenue Market Share Regions in 2016
Table EMEA MAb Biosimilars Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Europe MAb Biosimilars Revenue and Growth Rate (2012-2017)
Table Europe MAb Biosimilars Sales (K Units) by Type (2012-2017)
Table Europe MAb Biosimilars Market Share by Type (2012-2017)
Figure Europe MAb Biosimilars Market Share by Type in 2016
Table Europe MAb Biosimilars Sales (K Units) by Application (2012-2017)
Table Europe MAb Biosimilars Market Share by Application (2012-2017)
Figure Europe MAb Biosimilars Market Share by Application in 2016
Table Europe MAb Biosimilars Sales (K Units) by Countries (2012-2017)
Table Europe MAb Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe MAb Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe MAb Biosimilars Sales Market Share by Countries in 2016
Table Europe MAb Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Europe MAb Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe MAb Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe MAb Biosimilars Revenue Market Share by Countries in 2016
Figure Germany MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure France MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure UK MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Russia MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Italy MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East MAb Biosimilars Sales (K Units) by Type (2012-2017)
Table Middle East MAb Biosimilars Market Share by Type (2012-2017)
Figure Middle East MAb Biosimilars Market Share by Type (2012-2017)
Table Middle East MAb Biosimilars Sales (K Units) by Applications (2012-2017)
Table Middle East MAb Biosimilars Market Share by Applications (2012-2017)
Figure Middle East MAb Biosimilars Sales Market Share by Application in 2016
Table Middle East MAb Biosimilars Sales Volume (K Units) by Countries (2012-2017)
Table Middle East MAb Biosimilars Sales Volume Market Share by Countries (2012-2017)
Figure Middle East MAb Biosimilars Sales Volume Market Share by Countries in 2016
Table Middle East MAb Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Middle East MAb Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East MAb Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East MAb Biosimilars Revenue Market Share by Countries in 2016
Figure Saudi Arabia MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Israel MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure UAE MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Iran MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Africa MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Africa MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa MAb Biosimilars Sales (K Units) by Type (2012-2017)
Table Africa MAb Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa MAb Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa MAb Biosimilars Sales Market Share by Type in 2016
Table Africa MAb Biosimilars Sales (K Units) by Application (2012-2017)
Table Africa MAb Biosimilars Sales Market Share by Application (2012-2017)
Figure Africa MAb Biosimilars Sales Market Share by Application (2012-2017)
Table Africa MAb Biosimilars Sales Volume (K Units) by Countries (2012-2017)
Table Africa MAb Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa MAb Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa MAb Biosimilars Sales Market Share by Countries in 2016
Table Africa MAb Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Africa MAb Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa MAb Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa MAb Biosimilars Revenue Market Share by Countries in 2016
Figure South Africa MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Table Biocon MAb Biosimilars Basic Information List
Table Biocon MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Biocon MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Biocon MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Celltrion MAb Biosimilars Basic Information List
Table Celltrion MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celltrion MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Celltrion MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Celltrion MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Dr. Reddy's Laboratories MAb Biosimilars Basic Information List
Table Dr. Reddy's Laboratories MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Hospira MAb Biosimilars Basic Information List
Table Hospira MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hospira MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Hospira MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Hospira MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table 3SBio MAb Biosimilars Basic Information List
Table 3SBio MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure 3SBio MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure 3SBio MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure 3SBio MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Accord Healthcare MAb Biosimilars Basic Information List
Table Accord Healthcare MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Accord Healthcare MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table AET Biotech MAb Biosimilars Basic Information List
Table AET Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AET Biotech MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure AET Biotech MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure AET Biotech MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Allergan MAb Biosimilars Basic Information List
Table Allergan MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Allergan MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Allergan MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Alvartis Pharma MAb Biosimilars Basic Information List
Table Alvartis Pharma MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Amega Biotech MAb Biosimilars Basic Information List
Table Amega Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Amega Biotech MAb Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Amgen MAb Biosimilars Basic Information List
Table Apotex MAb Biosimilars Basic Information List
Table BioXpress Therapeutics MAb Biosimilars Basic Information List
Table Natco Pharma MAb Biosimilars Basic Information List
Table Sanifo MAb Biosimilars Basic Information List
Table Synthon MAb Biosimilars Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of MAb Biosimilars
Figure Manufacturing Process Analysis of MAb Biosimilars
Figure MAb Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of MAb Biosimilars Major Manufacturers in 2016
Table Major Buyers of MAb Biosimilars
Table Distributors/Traders List
Figure EMEA MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA MAb Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA MAb Biosimilars Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA MAb Biosimilars Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA MAb Biosimilars Sales Market Share Forecast by Region (2017-2022)
Table EMEA MAb Biosimilars Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA MAb Biosimilars Revenue Market Share Forecast by Region (2017-2022)
Table Europe MAb Biosimilars Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe MAb Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Europe MAb Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe MAb Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East MAb Biosimilars Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East MAb Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Middle East MAb Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East MAb Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Africa MAb Biosimilars Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa MAb Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Africa MAb Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa MAb Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA MAb Biosimilars Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA MAb Biosimilars Sales Market Share Forecast by Type (2017-2022)
Table EMEA MAb Biosimilars Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA MAb Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources